Comparison of the direct platelet immunofluorescence test (direct PIFT) with a modified direct monoclonal antibody-specific immobilization of platelet antigens (direct MAIPA) in detection of platelet-associated IgG.
Joutsi L, Kekomäki R.
Br J Haematol. 1997 Jan;96(1):204-9. doi: 10.1046/j.1365-2141.1997.d01-1995.x.
A microplate ELISA for the detection of platelet alloantibodies: comparison with the platelet immunofluorescence test.
Sintnicolaas K, van der Steuijt KJ, van Putten WL, Bolhuis RL.
Br J Haematol. 1987 Jul;66(3):363-7. doi: 10.1111/j.1365-2141.1987.tb06924.x.
Sensitivity of the platelet immunofluorescence test (PIFT) and the MAIPA assay for the detection of platelet-reactive alloantibodies: a report on two U.K. National Platelet Workshop exercises.
Allen DL, Chapman J, Phillips PK, Ouwehand WH.
Transfus Med. 1994 Jun;4(2):157-64. doi: 10.1111/j.1365-3148.1994.tb00257.x.
Platelet antibody detection assays: a single-laboratory comparison of MAIPA, PIFT, and microsphere-based multiplex assays Pak-Lx.
Costa TH, Bonet-Bub C, Kutner JM.
Hematol Transfus Cell Ther. 2024 Nov;46 Suppl 5(Suppl 5):S97-S102. doi: 10.1016/j.htct.2024.06.004. Epub 2024 Sep 7.
A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K, Löwenberg B.
Br J Haematol. 1996 Mar;92(4):1005-10. doi: 10.1046/j.1365-2141.1996.414953.x.
Detection of alloimmunization in Glanzmann Thrombasthenia and Bernard-Soulier Syndrome: Data from a Brazilian Center.
Gabe C, Ziza KC, Durazzo N, Pagani FM, Oliveira VB, Conrado MAV, Dezan MR, Mendrone A Jr, Villaça PR, Dinardo CL, Rocha V.
Hematol Transfus Cell Ther. 2023 Jul;45 Suppl 2(Suppl 2):S101-S107. doi: 10.1016/j.htct.2022.06.005. Epub 2022 Jul 20.
Detection of HLA antibodies by platelet crossmatching techniques.
McGrath K, Holdsworth R, Veale M, Bishop J, Wolf M.
Transfusion. 1988 May-Jun;28(3):214-6. doi: 10.1046/j.1537-2995.1988.28388219145.x.
The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
Levin MD, van der Holt B, de Veld JC, Gratama JW, de Vries W, van't Veer MB.
Vox Sang. 2004 Nov;87(4):291-8. doi: 10.1111/j.1423-0410.2004.00582.x.
The relevance of a bank with genotyped platelets donors.
Barbagallo NBA, Costa TH, Bastos E, Aravechia MG, Kutner JM, Bonet-Bub C.
Hematol Transfus Cell Ther. 2022 Oct-Dec;44(4):465-471. doi: 10.1016/j.htct.2021.03.006. Epub 2021 May 18.
Screening for alloantibodies in the serum of patients receiving platelet transfusions: a comparison of the ELISA, lymphocytotoxicity, and the indirect immunofluorescence method.
Levin MD, de Veld JC, van der Holt B, van't Veer MB.
Transfusion. 2003 Jan;43(1):72-7. doi: 10.1046/j.1537-2995.2003.00254.x.
